Algae, Tree, Herbs, Bush, Shrub, Grasses, Vines, Fern, Moss, Spermatophyta, Bryophyta, Fern Ally, Flower, Photosynthesis, Eukaryote, Prokaryote, carbohydrate, vitamins, amino acids, botany, lipids, proteins, cell, cell wall, biotechnology, metabolities, enzymes, agriculture, horticulture, agronomy, bryology, plaleobotany, phytochemistry, enthnobotany, anatomy, ecology, plant breeding, ecology, genetics, chlorophyll, chloroplast, gymnosperms, sporophytes, spores, seed, pollination, pollen, agriculture, horticulture, taxanomy, fungi, molecular biology, biochemistry, bioinfomatics, microbiology, fertilizers, insecticides, pesticides, herbicides, plant growth regulators, medicinal plants, herbal medicines, chemistry, cytogenetics, bryology, ethnobotany, plant pathology, methodolgy, research institutes, scientific journals, companies, farmer, scientists, plant nutrition
Select Language:
 
 
 
 
Main Menu
Please click the main subject to get the list of sub-categories
 
Services offered
 
 
 
 
  Section: Molecular Biology of Plant Pathways » Engineering Formation of Medicinal Compounds in Cell Cultures
 
 
Please share with your friends:  
 
 

Future Perspectives

 
     
 

The most common problems for the commercial application of metabolite production in cell culture systems are low productivity and the high cost associated with the maintenance of cell cultures, compared to harvesting in the field; for example, morphine is not produced in cultured Papaver cells and only low levels of vinblastine are produced in cultured Catharanthus cells. However, molecular engineering is a powerful tool and may be able to overcome these problems. First, other aspects of cell culture will need to be clarified for production. For example, while it is clear that selected cultured Coptis cells are superior to naturally grown Coptis rhizomes with regard to berberine production and uniform metabolite composition, these cultured cells are not accepted as being equivalent to natural rhizome. Since it has often been reported that In vitro-cultured cells/tissues have different metabolite profiles than intact tissues (Fu, 1998; Yamazaki et al., 2003), the safety of these materials for direct use as natural medicines has been questioned. Thus, cultured cells require additional certification to be considered equivalent to Coptis rhizome. On the other hand, the costs of tedious downstream processing to purify berberine from cultured Coptis cells cannot compete with that obtained by wild harvest from other sources, if metabolic engineering is not applicable. The size of the anticipated market is another important factor for commercialization.

So far, three metabolites produced in cultured cells/roots have been reported to be successfully commercialized (Table 11.1). One is cultured ginseng, the extract of which has been approved as a food additive with a market of $3 million in 1995 (Fu, 1998). The other two products are used in cosmetics: polysaccharides produced by cultured Polyanthes tuberosa cells (Honda et al., 1996) and Saiko extracts from cultured Saiko (Bupleurum falcatum L.) roots (Kusakari et al., 2000). In the latter cases, researchers found that polysaccharides and saikosaponins had novel activities regarding skin protection and developed their use as cosmetics. These successes clearly indicate that the discovery of novel product activities is essential for commercial development, except for a few chemicals such as paclitaxel, which have a high price and high demand. Functional evaluation of the metabolic profile in plant cells is crucial for the future engineering of medicinal compounds.
 
     
 
 
     



     
 
Copyrights 2012 © Biocyclopedia.com | Disclaimer